The Affera system, with its globular Sphere-9 catheter, was acquired by Medtronic in August 2022 through its $925 million purchase of the device’s eponymous developer. Not long thereafter ...

The first-ever pacemaker to include Managed Ventricular Pacing (MVP®), the EnRhythm™ Pacing System promotes intrinsic conduction and is clinically proven to significantly reduce unnecessary ...

There were 13 adverse events related to the intervention in 59 people, three of them related to the Reveal LINQ ICM system ..

Medtronic has announced new clinical study results showcasing a high durable lesion formation rate for the PulseSelect pulsed ...

A complete system, consisting of a Medtronic Revo MRI SureScan IPG implanted with two CapSureFix MRI™ SureScan leads is required for use in the MRI environment. The Revo MRI™ Pacing System ...

Medtronic has announced US Food and Drug Administration (FDA) approval to conduct an early feasibility study using the Affera Mapping and Ablation System for sustained VT, a serious heart condition.

Whether it’s Amazon’s poor workplace safety record, inequity in the juvenile justice system or exploitation at drug rehabs, Reveal connects with listeners through gripping and compassionate ...

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter. This innovative, all-in-one system ...

System Mechanic is an easy solution for optimal PC performance and simple computing. Once downloaded, it helps speed up slow computers by removing unnecessary software and files and fixes problems ...

A positive recommendation from NICE sends a powerful signal to the health and care system that your product should be adopted. We work closely with our system partners and industry to drive innovation ...

Need a new idea to keep kids entertained? Try stargazing. Free learning activities and videos about the solar system Free learning activities and videos about the solar system Free learning ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...